GLP-1 receptor agonists hold key market opportunities due to their effectiveness in diabetes and obesity management, expanding to cardiovascular and neurodegenerative disorders. Innovations like oral formulations and dual-agonist therapies boost adoption and …
Dublin, March 04, 2026 (GLOBE NEWSWIRE) -- The "GLP-1 Receptor Agonist - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.
The global market for GLP-1 Rec… [+10308 chars]









